Ananas Nanotech

Ananas Nanotech is an Italian biotechnology company and spin-off of the University of Padua, founded in 2007. The company is dedicated to developing and commercializing analytical, diagnostic, and drug delivery systems based on its proprietary Avidin-Nucleic-Acid-NanoASsemblies (ANANAS) platform. This technology utilizes poly-avidin nanoparticles formed by the self-assembly of avidin around a nucleic acid core, allowing for precise stoichiometric control and high-density loading of biotinylated functional elements (such as drugs, targeting ligands, or imaging agents). Ananas Nanotech's preclinical pipeline focuses on targeted drug delivery and diagnostics for indications including inflammatory bowel disease, autoimmune hepatitis, amyotrophic lateral sclerosis, and oncology. The company operates as a private entity and has collaborated with various academic institutions, including the University of Padua and the Mario Negri Institute.